The new share issue provides ADDvise with 15.2 million SEK and 1200 new shareholders
The new share issue of ADDvise for a maximum of 9 000 000 B-shares was subscribed to 7 229 300 and will mean that the company will increase the number of shareholders by about 1200. The issue provides the company with about 15.2 million SEK before transaction costs. The subscription price has been set at 2.10 SEK per B-share, which is eight percent lower than the volume weighted average price during the subscription period from January 15th to January 26th 2016.
The purpose of the issue was to gain a greater spread of ownership of the company and to raise capital to finance future acquisition and to further strengthen its financial position. A greater spread of ownership creates conditions for a better share liquidity before the planned listing on the Nasdaq Stockholm.
The contract note will be sent to those allotted immediately and delivery of the new shares is expected to take place on January 29th 2016.
The total number of shares will, after the registration with the Swedish Companies Registration Office (Bolagsverket), amount to 22 468 178 shares divided on 7 619 439 A-shares and 14 848 739 B-shares. The issue increases the share capital of the company by 7 229 300 SEK whereby the share capital of the Company after registration with the Companies Office will amount to 22 468 178 SEK.
For further information, please contact:
Rikard Akhtarzand, CEO, +46 765-25 90 71
About ADDvise Group AB
ADDvise Group AB (publ) is an expansive group which through its subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical Tables Inc offers comprehensive solutions in the form of products and services to healthcare and research facilities. ADDvise Group's customers are located in both the private and public sectors. The Company's share is listed on First North Premier and Mangold Fondkommission AB, +46 8-503015 50, is the company's Certified Adviser and liquidity provider.